Healthcare IT Today

NOVEMBER 6, 2023

” The acquisition follows AllStripes’ $50 million Series B funding round in 2021 and PicnicHealth’s $60 million Series C round in 2022. . “PicnicHealth will continue both companies’ work to harness the power of patient data to support biomedical research.” Originally announced October 23rd, 2023

Life Science 90

Life Science Drug Development Patient Experience healthcare technology 90

Healthcare IT News - Telehealth

FEBRUARY 11, 2022

The companies drew particular attention to Labcorp Drug Development, which Ascension says it can use to present physicians and patients with access to clinical trials, innovative therapies and new treatment options where appropriate. Labcorp also said it would use proprietary analytic tools and processes to improve overall efficiency.

Drug Development 155

Drug Development Healthcare IT 155

Healthcare IT Today

JUNE 26, 2022

The Office of the National Coordinator for Health IT has some money for you. The latest Leading Edge Acceleration Projects (LEAP) in Health IT funding opportunity will award grants to applicants working in two areas.

Drug Development 71

Drug Development Healthcare IT Health IT EHR 71

Healthcare IT Today

AUGUST 7, 2022

Data platform H1 is teaming with Lokavant , a clinical trial analytics vendor, to help clinical trial teams determine the best sites for trials in an effort to accelerate drug development.

eCare 86

eCare Digital Health Drug Development Healthcare IT 86

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics, and digital health companies, as well as early-stage VC funds.

Life Science 88

Life Science Drug Development HC BioTech 88

Healthcare IT Today

NOVEMBER 1, 2022

The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology. Originally announced October 25th, 2022. In conjunction, COTA announced it has raised additional capital from existing investors.

Life Science 85

Life Science Drug Development Digital Health Health IT 85

Digital Health Global

NOVEMBER 2, 2023

Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. 2021 [6] Regina M.

Drug Development 88

Drug Development Pharmaceuticals Public Health Telehealth 88

Healthcare IT Today

NOVEMBER 14, 2022

In 2022, AngelEye is on pace to deliver nearly 10 million virtual bedside visits. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development. Originally announced November 10th, 2022. About AngelEye Health. For more information, visit www.mtngp.com. About SeedtoB.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A For the year ended March 31, 2022, the company had global revenues of approximately 2.5 Originally announced December 19th, 2022.

Pharmaceuticals 59

Pharmaceuticals Drug Development Medical Technology Healthcare IT 59

DrKumo Remote Patient Monitoring

APRIL 12, 2022

Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022.

Drug Development 97

Drug Development 97

Lloyd Price

JUNE 17, 2023

2022: Teladoc faces challenges in the market for digital health. As the ability to collect and analyze large amounts of patient data grows, there is a growing opportunity for companies to develop personalized treatments and care plans. This could create a company that is able to develop and deliver personalized treatments to patients.

Digital Health 81

Digital Health Drug Development Telemedicine Telehealth 81

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., As of the end of 2022, the total size of funds reached US$865 million.

Drug Development 167

Drug Development Pharmaceuticals Life Science Digital Health 167

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” CAGR 2022-2032) market.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

DrKumo Remote Patient Monitoring

FEBRUARY 29, 2024

The Explosive Growth of Generative AI in Healthcare Market by 2032 According to a report from finance.yahoo.com, the global market for generative AI in healthcare, which was estimated at $1,070 million in 2022, is forecasted to surge to around $21,740 million by the year 2032. What are the benefits of AI in drug development?

Mental health 40

Mental health Health Data Drug Development Patient Experience 40

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. percent in 2022, the lowest the industry has seen in decades,” said Orr Inbar, CEO and Co-Founder of QuantHealth. This happens because there are major gaps in the research needed to support clinical trials.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Healthcare IT Today

OCTOBER 18, 2022

Redi.Health recently forged partnerships with several healthcare heavyweights like GoodRx and ScriptDrop, as well as a collaboration with Labcorp that integrates the Labcorp Drug Development Patient Access Solutions with Redi.Health’s digital support platform to more seamlessly connect patients and providers. .

Pharmaceuticals 54

Pharmaceuticals Drug Development Health IT Healthcare IT 54

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Several big players have joined the DTA, which doubled in membership in 2022. Big Pharma is driving much of the speculation. They include Astellas Pharma Inc.,

Digital Health 52

Digital Health Drug Development Pharmaceuticals EHR 52

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development.

BioTech 88

BioTech Life Science Leadership Drug Development 88

Healthcare IT Today

NOVEMBER 7, 2023

A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 billion in 2022, with an average 7.1-year Moreover, the vast majority of drug candidates do not reach the finish line, and many fail the clinical phase even though the biology works. year deployment time.

Drug Development 64

Drug Development BioTech Pharmaceuticals Health IT 64